Overall, taken together, these results indicate that MAP17 expression correlated with the increased expression of the two most important and limiting enzymes of NAD biosynthesis, NAMPT and NAPRT, which are also upregulated in pancreatic cancer. This evidence concerns the gene PDZK1IP1 and familial pancreatic carcinoma.